跳至主要内容
临床试验/EUCTR2012-000956-32-NL
EUCTR2012-000956-32-NL进行中(未招募)不适用

Pharmacokinetics of intravenous acetaminophen and its metabolites in morbidly obese patients - APAP study

St. Antonius Ziekenhuis0 个研究点开始时间: 2012年4月24日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Inclusion criteria for morbidly obese patients:
  • - BMI > 40 kg/m2 undergoing bariatric surgery.
  • - 18 -60 years old
  • - ASA physical classification of II or III
  • - All racial and ethnic groups will be included
  • Inclusion criteria for normal weight patients:
  • - BMI between 18 and 25 kg/m2 undergoing general surgery
  • - 18 -60 years old
  • - ASA physical classification of I, II or III
  • - All racial and ethnic groups will be included
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 28
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Exclusion criteria for all patient groups:
  • - Renal insufficiency identified by GFR < 60 ml/min/1.73m2
  • - Liver disease identified by liver function tests: ASAT, ALAT, prothrombin time, ?-GT, bilirubin, creatinine, albumin and alkaline phosphatase (ALP) ( > 3 times upper limit of normal values)
  • - Patients with Gilbert-Meulendracht syndrome
  • - Chronic alcohol intake or use of alcohol within last 72 hours
  • - Pregnancy or breastfeeding
  • - Patients who are treated with drugs know to affect CYP2E1 and UGT (UDP-glucuronyltransferases)
  • - Diabetes mellitus type II patients
  • - Acetaminophen intake before the study (24 hours before study)

研究者

相似试验